Dr. Timourian is a former university mathematics professor and successful investor in technology companies. He possesses a PhD in Mathematics.
Chief Operating Officer
Dr. Omar is a biofilm expert, having completed his Ph.D. at Manchester University in England. He is responsible for meeting client needs through the provision of contract research services to a wide scope of companies including medical devices, biotech, oil & gas, pharmaceutical, consumer products and food processing. His team provides a range of services including initial screening of antimicrobial candidates through to scientific studies for regulatory approval. His largest single client group is the medical device industry seeking standardized testing for antimicrobial coatings. This testing is used for regulatory submissions to the US Food & Drug Administration. He is also responsible for the overall operation of Innovotech.
Quality and Safety Director
Dr. Nadworny is a professional engineer with a Ph.D. from the University of Alberta in Chemical Engineering and Biomedical Engineering. Dr. Nadworny is a silver expert and has contributed to the development of Innovotech antimicrobial products as well as maintaining our patent portfolios. Dr. Nadworny is currently responsible for maintaining and managing the ISO 17025 quality system and overall safety aspects of the company.
Dr. Boone received his Ph.D. in Medical Sciences from the University of Alberta in 2012. He then spent 5 years as a Postdoctoral fellow, studying spore formation, at Loyola University Chicago. Dr. Boone joined Innovotech in 2017 and manages a team that provides standardized testing for contract research as well as to support the development of Innovotech’s antimicrobial products.
Board of Directors
Chairman and SecretaryDr. Timourian is a former university mathematics professor and successful investor in technology companies. He possesses a PhD in Mathematics.
David S. Tam
Mr. Tam possesses extensive legal background in the creation and financing of knowledge-based companies including Board Directorship in many of these companies. He is currently a partner at Parlee McLaws of Edmonton. David holds a Bachelor degree in Pharmacy and a Bachelor of Law degree from the University of Alberta.
Mr. Savage is founder and president of Lonsdale Capital Corporation of Vancouver. Alan is currently the Chief Financial Officer. He brings to Innovotech experience and expertise in capital markets obtained over a long and successful career in finance and investment.
Bernard is Director of Corporate Services at Givens LLP. He is an experienced accountant serving public and private companies at international and national accounting firms. He currently provides contract Controllership and consulting services (including IFRS services) to his clients. He is a chartered accountant in Canada and South Africa.
Dr. Muhs has had an outstanding career in pharmaceutical manufacturing and executive level management. He has served at an executive level for Laporte PLC, Degussa GmbH and Rhodia Pharma Solutions. He holds a PhD in organic chemistry.
Dr. Tertzakian has over 30 years’ experience in the creation, management, and financing of knowledge based companies. He is past Chair & CEO of Innovotech, Raylo Chemicals and Cytovax. He possesses a PhD in organic chemistry.